ST. CATHARINES, ON, June 26 /CNW/ - The Ontario Pharmacists' Association
(OPA) is bringing the Safe Meds for Heart program to your community. OPA has
taken pride in the development and delivery of the Safe Meds for Heart in
partnership with AstraZeneca Canada Inc. and Pfizer Canada Inc. These seminars
offer a tremendous value to seniors, and their loved ones, who face heart
Did you know that heart disease is the leading cause of death in Canada?
Approximately half of all seniors have high blood. Lack of education on the
appropriate usage of medications can lead to their misuse, and proper use of
medications can avoid costly visits to the emergency room and hospitalization.
MPP Jim Bradley will host a free seminar on Safe Meds for Heart for
seniors in St. Catharines. The Safe Meds for Heart provides a forum for
seniors to learn about high blood pressure, cholesterol and angina from
practicing community pharmacists who are experts in providing advice to
patients on the safe use of medications.
You are invited to see first hand the significant value that this seminar
has to offer seniors in your community.
WHAT: Join us at a free seminar on safe medication use for heart
health for seniors, where a local Pharmacist will provide
seniors with important information on appropriate use of
WHEN: Thursday, June 28, 2007,
WHERE: Niagara Ina Grafton Gage Village
413 Linwell Road
St. Catharines, ON L2M 7Y2
WHO: MPP Jim Bradley will host the seminar
WHY: Heart disease is the leading cause of death in Canada.
Approximately half of all seniors have high blood pressure.
Lack of education on the appropriate usage of medications can
lead to their misuse.
For further information:
For further information: or to set-up an interview, please contact:
Mary-Anne Cedrone, Manager of Communications, Ontario Pharmacists'
Association, Tel: (416) 441-0788, Email: email@example.com; Jennifer
McCormack, Communications Specialist, AstraZeneca Canada, Tel: (905) 615-6837,
Email: firstname.lastname@example.org; Christian Marcoux, Manager,
Corporate Communications, Pfizer Canada Inc., Tel: (514) 426-6985, Email: